Matches in SemOpenAlex for { <https://semopenalex.org/work/W3163100624> ?p ?o ?g. }
- W3163100624 endingPage "2022" @default.
- W3163100624 startingPage "2012" @default.
- W3163100624 abstract "Abstract Immune checkpoint inhibitors (ICIs), immunomodulatory antibodies that are used to enhance the immune system, have substantially improved the prognosis of patients with advanced malignancy. As the use of ICI therapy becomes increasingly widespread across different types of cancer, their use in patients receiving dialysis is likely to increase. In this review we summarize the current literature on the use of ICIs in end-stage kidney disease (ESKD) patients and provide aggregate data from reported cases and series. Based on available pharmacological information, ICIs require no dosing adjustment in ESKD patients. Analysis of the reported cases in the literature demonstrates a similar incidence of immune-related adverse events in patients with ESKD receiving dialysis as compared with the general population (49%). Severe reactions graded as 3 and 4 have been seen in 15 patients (16%). As such, it is important that these patients are monitored very closely for immune-related adverse events; however, the risk of these adverse events should not preclude patients on dialysis from receiving these therapies. Cancer remission (complete and partial) was seen in close to 30% of patients, stable disease was seen in 28% and progression of disease in ∼36%. One-third of the patients died. Urothelial and renal cell cancer represented approximately half of all treated cancers and accounted for ∼50% of all deaths reported. Additional data in the dialysis population with the use of ICIs and involvement in prospective studies are needed to better assess outcomes, particularly within specific cancer types." @default.
- W3163100624 created "2021-05-24" @default.
- W3163100624 creator A5015498310 @default.
- W3163100624 creator A5018399640 @default.
- W3163100624 creator A5040646631 @default.
- W3163100624 creator A5049148114 @default.
- W3163100624 creator A5053240410 @default.
- W3163100624 date "2021-05-08" @default.
- W3163100624 modified "2023-10-18" @default.
- W3163100624 title "Immune checkpoint inhibitor use in patients with end-stage kidney disease: an analysis of reported cases and literature review" @default.
- W3163100624 cites W1950972410 @default.
- W3163100624 cites W1966280949 @default.
- W3163100624 cites W1968529445 @default.
- W3163100624 cites W1970875728 @default.
- W3163100624 cites W1987380247 @default.
- W3163100624 cites W1995731982 @default.
- W3163100624 cites W2018956144 @default.
- W3163100624 cites W2019958335 @default.
- W3163100624 cites W2054509906 @default.
- W3163100624 cites W2059050919 @default.
- W3163100624 cites W2142692547 @default.
- W3163100624 cites W2206155940 @default.
- W3163100624 cites W2223436478 @default.
- W3163100624 cites W2295766629 @default.
- W3163100624 cites W2300181798 @default.
- W3163100624 cites W2303235652 @default.
- W3163100624 cites W2434614187 @default.
- W3163100624 cites W2479623580 @default.
- W3163100624 cites W2521230355 @default.
- W3163100624 cites W2529221862 @default.
- W3163100624 cites W2560460441 @default.
- W3163100624 cites W2564934728 @default.
- W3163100624 cites W2569887568 @default.
- W3163100624 cites W2578082697 @default.
- W3163100624 cites W2615652585 @default.
- W3163100624 cites W2728093281 @default.
- W3163100624 cites W2731921472 @default.
- W3163100624 cites W2736166064 @default.
- W3163100624 cites W2736402482 @default.
- W3163100624 cites W2750116245 @default.
- W3163100624 cites W2783137027 @default.
- W3163100624 cites W2786816161 @default.
- W3163100624 cites W2802155618 @default.
- W3163100624 cites W2806258060 @default.
- W3163100624 cites W2807876762 @default.
- W3163100624 cites W2809202750 @default.
- W3163100624 cites W2887100701 @default.
- W3163100624 cites W2896274372 @default.
- W3163100624 cites W2897541686 @default.
- W3163100624 cites W2900108152 @default.
- W3163100624 cites W2904477283 @default.
- W3163100624 cites W2911491919 @default.
- W3163100624 cites W2913058282 @default.
- W3163100624 cites W2919428266 @default.
- W3163100624 cites W2940093782 @default.
- W3163100624 cites W2943781197 @default.
- W3163100624 cites W2945240124 @default.
- W3163100624 cites W2956566890 @default.
- W3163100624 cites W2965287698 @default.
- W3163100624 cites W2967411293 @default.
- W3163100624 cites W2972951159 @default.
- W3163100624 cites W2980552457 @default.
- W3163100624 cites W2998446840 @default.
- W3163100624 cites W2999447726 @default.
- W3163100624 cites W3009081800 @default.
- W3163100624 cites W3011659135 @default.
- W3163100624 cites W3023745224 @default.
- W3163100624 cites W3024361750 @default.
- W3163100624 cites W3031410799 @default.
- W3163100624 cites W3039947830 @default.
- W3163100624 cites W3046471034 @default.
- W3163100624 cites W3048702451 @default.
- W3163100624 cites W3088222562 @default.
- W3163100624 cites W3093208317 @default.
- W3163100624 cites W3097930466 @default.
- W3163100624 cites W3103317849 @default.
- W3163100624 cites W3108137730 @default.
- W3163100624 cites W3109609149 @default.
- W3163100624 cites W3113062413 @default.
- W3163100624 cites W3115335364 @default.
- W3163100624 cites W3127209394 @default.
- W3163100624 cites W3134194278 @default.
- W3163100624 cites W3158326626 @default.
- W3163100624 cites W4367664545 @default.
- W3163100624 cites W607339271 @default.
- W3163100624 doi "https://doi.org/10.1093/ckj/sfab090" @default.
- W3163100624 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8406068" @default.
- W3163100624 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34476087" @default.
- W3163100624 hasPublicationYear "2021" @default.
- W3163100624 type Work @default.
- W3163100624 sameAs 3163100624 @default.
- W3163100624 citedByCount "24" @default.
- W3163100624 countsByYear W31631006242021 @default.
- W3163100624 countsByYear W31631006242022 @default.
- W3163100624 countsByYear W31631006242023 @default.
- W3163100624 crossrefType "journal-article" @default.
- W3163100624 hasAuthorship W3163100624A5015498310 @default.
- W3163100624 hasAuthorship W3163100624A5018399640 @default.